itaconic acid has been researched along with Neoplasms in 5 studies
itaconic acid : A dicarboxylic acid that is methacrylic acid in which one of the methyl hydrogens is substituted by a carboxylic acid group.
Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Undesirable effects of cancer therapeutics are a major reason for drug-associated toxicity, which confounds drug dosing and efficacy." | 2.66 | The promise and peril of targeting cell metabolism for cancer therapy. ( Weiss, JM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F | 1 |
| Dowerg, B | 1 |
| Cordes, T | 1 |
| Weiss, JM | 1 |
| Ryan, DG | 1 |
| Murphy, MP | 1 |
| Frezza, C | 1 |
| Prag, HA | 1 |
| Chouchani, ET | 1 |
| O'Neill, LA | 1 |
| Mills, EL | 1 |
| Sun, Y | 1 |
| Li, Y | 1 |
| Nan, S | 1 |
| Zhang, L | 1 |
| Huang, H | 1 |
| Wang, J | 1 |
3 reviews available for itaconic acid and Neoplasms
| Article | Year |
|---|---|
The yin and yang of itaconate metabolism and its impact on the tumor microenvironment.
Topics: Humans; Neoplasms; Succinates; Succinic Acid; Tumor Microenvironment | 2023 |
The promise and peril of targeting cell metabolism for cancer therapy.
Topics: Animals; Antineoplastic Agents; Biomarkers; Cell Communication; Energy Metabolism; Humans; Immunomod | 2020 |
Coupling Krebs cycle metabolites to signalling in immunity and cancer.
Topics: Citric Acid Cycle; Humans; Immunity, Innate; Macrophages; Neoplasms; Signal Transduction; Succinate | 2019 |
2 other studies available for itaconic acid and Neoplasms
| Article | Year |
|---|---|
Myeloid-Derived Itaconate Suppresses Antitumor Immunity.
Topics: CD8-Positive T-Lymphocytes; Humans; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoplasms | 2023 |
Myeloid-Derived Itaconate Suppresses Antitumor Immunity.
Topics: CD8-Positive T-Lymphocytes; Humans; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoplasms | 2023 |
Myeloid-Derived Itaconate Suppresses Antitumor Immunity.
Topics: CD8-Positive T-Lymphocytes; Humans; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoplasms | 2023 |
Myeloid-Derived Itaconate Suppresses Antitumor Immunity.
Topics: CD8-Positive T-Lymphocytes; Humans; Myeloid Cells; Myeloid-Derived Suppressor Cells; Neoplasms | 2023 |
Synthesis and characterization of pH-sensitive poly(itaconic acid)-poly(ethylene glycol)-folate-poly(l-histidine) micelles for enhancing tumor therapy and tunable drug release.
Topics: Antineoplastic Agents; Cell Survival; Drug Delivery Systems; Drug Liberation; Folic Acid; HeLa Cells | 2015 |